# Shionogi: Phase 1 study in Renal Impairment (30 participants)

**Score:** 50/100

| Field | Value |
|---|---|
| Sponsor | Shionogi |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy Controls |
| NCT ID | NCT07857837 |
| Phase | Phase 1 |
| Status | not yet recruiting |
| Conditions | Renal Impairment |
| Intervention types | drug |
| Target enrollment | 30 |
| Site countries | United States |
| Posted | 2026-10-05 |
| Planned start | 2026-09-29 |
| Event | Newly registered study |
| Event date | 2026-10-05 |

## Why this score
- Industry sponsor (buys outsourced services).
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07857837). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.